The insulin-mimetic agent vanadate promotes receptor endocytosis and inhibits intracellular ligand-receptor degradation by a mechanism distinct from the lysosomotropic agents.

Source:http://linkedlifedata.com/resource/pubmed/id/8690156

Download in:

View as

General Info

PMID
8690156